The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

potentially category-defining anti-PRLR antibody in development for androgenic alopecia Leading AI platform demonstrated breakthrough in successful de novo design of antibody targeting previously ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination.

Aphios announced today that it was awarded an NIH SBIR grant from the National Institute on Aging (NIA) to develop anti-CCR5 nanoparticles to treat Al ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...

In 25 years, new HIV infections in South Africa have dropped from around 1,463 each day to about 370. But HIV is still an ...

Anti-seizure medications, which are also called anticonvulsants ... Dilantin is available in capsule, chewable pill, oral solution, and IV form. This drug interacts with nerve cell sodium channels.